Intersect ENT

+$0.04 (+0.15%) As of 3:00 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Intersect ENT and other ETFs, options, and stocks.

About XENT

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA.

CEO
Thomas A. West
Employees
406
Headquarters
Menlo Park, California
Founded
2003

XENT Key Statistics

Market Cap
905.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
281.50K
High Today
$27.29
Low Today
$27.14
Open Price
$27.20
Volume
174.70K
52 Week High
$28.17
52 Week Low
$14.68

XENT Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure